Table 1.
EE-TP Attributes | Criteria |
---|---|
Dosage Form | ~58–65 × 1010 erythrocytes suspended in saline |
Thymidine-phosphorylase/erythrocytes ratio | ~30–90 U/1010 erythrocytes |
Dosage Volume | ~150–500 mL |
Route of Administration | IV |
Physical Description | Light to dark red color, resembling venous blood |
EE-TP—erythrocyte encapsulated thymidine phosphorylase; IV—intravenous.